BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sehgal K, Yadav D, Khanna S. The interplay of Clostridioides difficile infection and inflammatory bowel disease. Therap Adv Gastroenterol 2021;14:17562848211020285. [PMID: 34104215 DOI: 10.1177/17562848211020285] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Marinescu AR, Laza R, Musta VF, Cut TG, Dumache R, Tudor A, Porosnicu M, Lazureanu VE, Licker M. Clostridium Difficile and COVID-19: General Data, Ribotype, Clinical Form, Treatment-Our Experience from the Largest Infectious Diseases Hospital in Western Romania. Medicina (Kaunas) 2021;57:1099. [PMID: 34684136 DOI: 10.3390/medicina57101099] [Reference Citation Analysis]
2 Cold F, Svensson CK, Petersen AM, Hansen LH, Helms M. Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study. Cells 2022;11:435. [DOI: 10.3390/cells11030435] [Reference Citation Analysis]
3 Khanna S, Pardi R. Clostridioides difficile infection: curbing a difficult menace. Therap Adv Gastroenterol 2022;15:175628482210899. [DOI: 10.1177/17562848221089906] [Reference Citation Analysis]